163 related articles for article (PubMed ID: 7020934)
1. Evidence for the involvement of N-hydroxylation of 3-amino-1-methyl-5H-pyrido[4,3-b]indole by cytochrome P-450 in the covalent binding to DNA.
Mita S; Ishii K; Yamazoe Y; Kamataki T; Kato R; Sugimura T
Cancer Res; 1981 Sep; 41(9 Pt 1):3610-4. PubMed ID: 7020934
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of mutagenic tryptophan pyrolysis products by rat liver microsomes.
Ishii K; Yamazoe Y; Kamataki T; Kato R
Cancer Res; 1980 Jul; 40(7):2596-600. PubMed ID: 6771001
[TBL] [Abstract][Full Text] [Related]
3. Species difference in N-hydroxylation of a tryptophan pyrolysis product in relation to mutagenic activation.
Yamazoe Y; Kamataki T; Kato R
Cancer Res; 1981 Nov; 41(11 Pt 1):4518-22. PubMed ID: 6796262
[TBL] [Abstract][Full Text] [Related]
4. Sex-dependent induction of hepatic enzymes for mutagenic activation of a tryptophan pyrolysate component, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]-indole, by feeding in mice.
Degawa M; Kojima M; Hishinuma T; Hashimoto Y
Cancer Res; 1985 Jan; 45(1):96-102. PubMed ID: 3880668
[TBL] [Abstract][Full Text] [Related]
5. Reactions of potent mutagens, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) with nucleic acid.
Hashimoto Y; Shudo K; Imamura M; Okamoto T
Nucleic Acids Symp Ser; 1980; (8):s109-12. PubMed ID: 7255181
[TBL] [Abstract][Full Text] [Related]
6. Catalysis of the covalent binding of 3-hydroxyamino-1-methyl-5H-pyrido[4,3-b]indole to DNA by a L-proline- and adenosine triphosphate-dependent enzyme in rat hepatic cytosol.
Yamazoe Y; Shimada M; Shinohara A; Saito K; Kamataki T; Kato R
Cancer Res; 1985 Jun; 45(6):2495-500. PubMed ID: 3986789
[TBL] [Abstract][Full Text] [Related]
7. DNA strand cleavage in vitro by 3-hydroxyamino-1-methyl-5H-pyrido[4,3-b]-indole, a direct-acting mutagen formed in the metabolism of carcinogenic 3-amino-1-methyl-5H-pyrido[4,3-b]indole.
Wakata A; Oka N; Hiramoto K; Yoshioka A; Negishi K; Wataya Y; Hayatsu H
Cancer Res; 1985 Nov; 45(11 Pt 2):5867-71. PubMed ID: 4053057
[TBL] [Abstract][Full Text] [Related]
8. Structural elucidation of a mutagenic metabolite of 3-amino-1-methyl-5H-pyrido[4,3-b]indole.
Yamazoe Y; Ishii K; Kamataki T; Kato R
Drug Metab Dispos; 1981; 9(3):292-6. PubMed ID: 6113943
[TBL] [Abstract][Full Text] [Related]
9. N-hydroxylation of carcinogenic and mutagenic aromatic amines.
Kato R; Kamataki T; Yamazoe Y
Environ Health Perspect; 1983 Mar; 49():21-5. PubMed ID: 6832094
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of a tryptophan pyrolysis product, 3-amino-1-methyl-5H-pyrido[4,3-b]indole(TRP-P-2) by isolated rat liver nuclei.
Mita S; Yamazoe Y; Kamataki T; Kato R
Cancer Lett; 1981 Dec; 14(3):261-6. PubMed ID: 6800639
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates.
Kato R
Crit Rev Toxicol; 1986; 16(4):307-48. PubMed ID: 3519087
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of the food mutagen 3-amino-1,4-dimethyl-5H-pyrido-[4,3-b]indole (Trp-P-1) in endothelial cells of cytochrome P-450-induced mice.
Brittebo EB; Brandt I
Cancer Res; 1994 Jun; 54(11):2887-94. PubMed ID: 8187073
[TBL] [Abstract][Full Text] [Related]
13. Glutathione transferase-mediated and non-enzymatic activation and detoxication of the N-hydroxy derivative of Trp-P-2, a potent pyrolysate promutagen.
Saito K; Yamazoe Y; Kamataki T; Kato R
Xenobiotica; 1984 Jul; 14(7):545-8. PubMed ID: 6506768
[TBL] [Abstract][Full Text] [Related]
14. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
Kamataki T; Maeda K; Yamazoe Y; Matsuda N; Ishii K; Kato R
Mol Pharmacol; 1983 Jul; 24(1):146-55. PubMed ID: 6408394
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA.
Frederick CB; Mays JB; Ziegler DM; Guengerich FP; Kadlubar FF
Cancer Res; 1982 Jul; 42(7):2671-7. PubMed ID: 7083159
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters.
Nohmi T; Mizokami K; Kawano S; Fukuhara M; Ishidate M
Jpn J Cancer Res; 1987 Feb; 78(2):153-61. PubMed ID: 3104258
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of 2-amino-9H-pyrido[2,3-b]indole by rat-liver microsomes.
Niwa T; Yamazoe Y; Kato R
Mutat Res; 1982 Aug; 95(2-3):159-70. PubMed ID: 6750381
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
[TBL] [Abstract][Full Text] [Related]
20. Formation of hydroxy derivatives, aldehydes, and nitrite from N-nitrosomethyl-n-amylamine by rat liver microsomes and by purified cytochrome P-450 IIB1.
Ji C; Mirvish SS; Nickols J; Ishizaki H; Lee MJ; Yang CS
Cancer Res; 1989 Oct; 49(19):5299-304. PubMed ID: 2766298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
